Side-by-side financials for BIOX and CF. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BIOX | CF |
|---|---|---|
| Market cap | - | $16.37 B |
| US-listed rank | - | #696 |
| Revenue (latest FY) | - | $7.08B |
| Net income (latest FY) | - | $1.54B |
| Net margin | - | 21.7% |
| P/E (trailing FY) | - | 10.6 |
| SEC filings | 270 | 2,200 |
Full pages: Bioceres Crop Solutions Corp. and CF Industries Holdings, Inc., or browse the full rankings.